ID   FUT9_RAT                Reviewed;         359 AA.
AC   Q99JB3;
DT   09-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   29-MAY-2024, entry version 129.
DE   RecName: Full=4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 {ECO:0000305};
DE            EC=2.4.1.152 {ECO:0000269|PubMed:11020213, ECO:0000269|PubMed:11675393};
DE   AltName: Full=Fucosyltransferase 9;
DE   AltName: Full=Fucosyltransferase IX {ECO:0000303|PubMed:11020213, ECO:0000303|PubMed:11675393};
DE            Short=Fuc-TIX {ECO:0000303|PubMed:11020213};
DE            Short=FucT-IX;
DE   AltName: Full=Galactoside 3-L-fucosyltransferase;
GN   Name=Fut9 {ECO:0000312|RGD:619955};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11675393; DOI=10.1074/jbc.m108495200;
RA   Shimoda Y., Tajima Y., Osanai T., Katsume A., Kohara M., Kudo T.,
RA   Narimatsu H., Takashima N., Ishii Y., Nakamura S., Osumi N., Sanai Y.;
RT   "Pax6 controls the expression of Lewis x epitope in the embryonic forebrain
RT   by regulating alpha 1,3-fucosyltransferase IX expression.";
RL   J. Biol. Chem. 277:2033-2039(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11020213;
RX   DOI=10.1002/1097-4547(20001015)62:2<206::aid-jnr5>3.0.co;2-e;
RA   Baboval T., Henion T., Kinnally E., Smith F.I.;
RT   "Molecular cloning of rat alpha1,3-fucosyltransferase IX (Fuc-TIX) and
RT   comparison of the expression of Fuc-TIV and Fuc-TIX genes during rat
RT   postnatal cerebellum development.";
RL   J. Neurosci. Res. 62:206-215(2000).
CC   -!- FUNCTION: Catalyzes alpha(1->3) linkage of fucosyl moiety transferred
CC       from GDP-beta-L-fucose to N-acetyl glucosamine (GlcNAc) within type 2
CC       lactosamine (LacNAc, beta-D-Gal-(1->4)-beta-D-GlcNAc-) glycan attached
CC       to glycolipids and N- or O-linked glycoproteins. Fucosylates distal
CC       type 2 LacNAc and its fucosylated (H-type 2 LacNAc) and sialylated
CC       (sialyl-type 2 LacNAc) derivatives to form Lewis x (Lex) (CD15) and
CC       Lewis y (Ley) antigenic epitopes involved in cell adhesion and
CC       differentiation (By similarity) (PubMed:11020213, PubMed:11675393).
CC       Generates Lex epitopes in the brain, presumably playing a role in the
CC       maintenance of neuronal stemness and neurite outgrowth in progenitor
CC       neural cells (By similarity). Fucosylates the internal type 2 LacNAc
CC       unit of the polylactosamine chain to form VIM-2 antigen that serves as
CC       recognition epitope for SELE (By similarity). Can also modify milk
CC       oligosaccharides in particular type 2 tetrasaccharide LNnT (By
CC       similarity). {ECO:0000250|UniProtKB:O88819,
CC       ECO:0000250|UniProtKB:Q9Y231, ECO:0000269|PubMed:11020213,
CC       ECO:0000269|PubMed:11675393}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl
CC         derivative + GDP-beta-L-fucose = a beta-D-galactosyl-(1->4)-[alpha-L-
CC         fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl derivative + GDP + H(+);
CC         Xref=Rhea:RHEA:14257, ChEBI:CHEBI:15378, ChEBI:CHEBI:57273,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:133507, ChEBI:CHEBI:137941;
CC         EC=2.4.1.152; Evidence={ECO:0000269|PubMed:11020213,
CC         ECO:0000269|PubMed:11675393};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14258;
CC         Evidence={ECO:0000269|PubMed:11020213, ECO:0000269|PubMed:11675393};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-
CC         beta-D-Gal-(1->4)-beta-D-GlcNAc derivative + GDP-beta-L-fucose = an
CC         alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-
CC         Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc derivative + GDP +
CC         H(+); Xref=Rhea:RHEA:68044, ChEBI:CHEBI:15378, ChEBI:CHEBI:57273,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:145343, ChEBI:CHEBI:176900;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68045;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-
CC         N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-
CC         acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-
CC         glucosyl-(1<->1')-ceramide + GDP-beta-L-fucose = alpha-N-
CC         glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-
CC         D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-
CC         (1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-
CC         beta-D-glucosyl-(1<->1')-ceramide + GDP + H(+); Xref=Rhea:RHEA:48388,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:90383, ChEBI:CHEBI:90384;
CC         Evidence={ECO:0000250|UniProtKB:O88819};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48389;
CC         Evidence={ECO:0000250|UniProtKB:O88819};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-
CC         beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-
CC         (1<->1')-ceramide + GDP-beta-L-fucose = a neolactoside IV(3)-alpha-
CC         Gal,III(3)-alpha-Fuc-nLc4Cer + GDP + H(+); Xref=Rhea:RHEA:48380,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:90380, ChEBI:CHEBI:90381;
CC         Evidence={ECO:0000250|UniProtKB:O88819};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48381;
CC         Evidence={ECO:0000250|UniProtKB:O88819};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside nLc4Cer + GDP-beta-L-fucose = a neolactoside
CC         III(3)-alpha-Fuc-nLc4Cer + GDP + H(+); Xref=Rhea:RHEA:48376,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:90376, ChEBI:CHEBI:90379;
CC         Evidence={ECO:0000269|PubMed:11020213, ECO:0000269|PubMed:11675393};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48377;
CC         Evidence={ECO:0000269|PubMed:11020213, ECO:0000269|PubMed:11675393};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-
CC         N-acetyl-beta-D-glucosaminyl derivative + GDP-beta-L-fucose = an
CC         alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-
CC         GlcNAc derivative + GDP + H(+); Xref=Rhea:RHEA:56076,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:136545, ChEBI:CHEBI:139509;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56077;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc
CC         + GDP-beta-L-fucose = beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-
CC         GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc + GDP + H(+);
CC         Xref=Rhea:RHEA:77187, ChEBI:CHEBI:15378, ChEBI:CHEBI:57273,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:60239, ChEBI:CHEBI:61352;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77188;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc
CC         derivative + GDP-beta-L-fucose = an alpha-L-Fuc-(1->2)-beta-D-Gal-
CC         (1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc derivative + GDP + H(+);
CC         Xref=Rhea:RHEA:77191, ChEBI:CHEBI:15378, ChEBI:CHEBI:57273,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:133510, ChEBI:CHEBI:195560;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77192;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y231};
CC   -!- ACTIVITY REGULATION: Activated by Mn2+. {ECO:0000250|UniProtKB:Q9Y231}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000250|UniProtKB:O88819, ECO:0000250|UniProtKB:Q9Y231}.
CC   -!- PATHWAY: Glycolipid biosynthesis. {ECO:0000250|UniProtKB:O88819}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q9Y231}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane
CC       {ECO:0000250|UniProtKB:Q9Y231}; Single-pass type II membrane protein
CC       {ECO:0000250|UniProtKB:Q6P4F1}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:O88819}.
CC   -!- DOMAIN: The donor-binding domain adopts a Rossman-like fold involved in
CC       GDP-beta-L-fucose sugar donor interactions.
CC       {ECO:0000250|UniProtKB:Q9Y231}.
CC   -!- DOMAIN: The acceptor-binding domain adopts a Rossman-like fold
CC       consisting of six-stranded parallel beta sheets characteristic of the
CC       Toll/interleukin-1 receptor (TIR) fold family. Interacts with the
CC       LacNAc unit of type 2 LacNAc and H-type 2 LacNAc structures. It
CC       contains the catalytic base Glu-137 which deprotonates the hydroxyl
CC       group of GlcNAc while forming bridging interactions with the donor
CC       sugar to position the catalytic machinery in the active site.
CC       {ECO:0000250|UniProtKB:Q9Y231}.
CC   -!- PTM: N-glycosylated with complex-type N-glycans.
CC       {ECO:0000250|UniProtKB:Q9Y231}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 10 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB049819; BAB40953.1; -; mRNA.
DR   EMBL; AF345993; AAK16591.1; -; mRNA.
DR   RefSeq; NP_445917.1; NM_053465.1.
DR   AlphaFoldDB; Q99JB3; -.
DR   SMR; Q99JB3; -.
DR   STRING; 10116.ENSRNOP00000011393; -.
DR   CAZy; GT10; Glycosyltransferase Family 10.
DR   GlyCosmos; Q99JB3; 3 sites, No reported glycans.
DR   GlyGen; Q99JB3; 3 sites.
DR   PhosphoSitePlus; Q99JB3; -.
DR   PaxDb; 10116-ENSRNOP00000011393; -.
DR   Ensembl; ENSRNOT00000113229.1; ENSRNOP00000087361.1; ENSRNOG00000070149.1.
DR   Ensembl; ENSRNOT00055017213; ENSRNOP00055013853; ENSRNOG00055010194.
DR   Ensembl; ENSRNOT00060023642; ENSRNOP00060018794; ENSRNOG00060013840.
DR   Ensembl; ENSRNOT00065008515; ENSRNOP00065006000; ENSRNOG00065005705.
DR   GeneID; 84597; -.
DR   KEGG; rno:84597; -.
DR   UCSC; RGD:619955; rat.
DR   AGR; RGD:619955; -.
DR   CTD; 10690; -.
DR   RGD; 619955; Fut9.
DR   eggNOG; KOG2619; Eukaryota.
DR   GeneTree; ENSGT00940000155095; -.
DR   HOGENOM; CLU_032075_4_2_1; -.
DR   InParanoid; Q99JB3; -.
DR   OMA; FRKWDSQ; -.
DR   OrthoDB; 1331128at2759; -.
DR   PhylomeDB; Q99JB3; -.
DR   TreeFam; TF316348; -.
DR   Reactome; R-RNO-9037629; Lewis blood group biosynthesis.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:Q99JB3; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000008475; Expressed in frontal cortex and 4 other cell types or tissues.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005802; C:trans-Golgi network; ISS:UniProtKB.
DR   GO; GO:0032588; C:trans-Golgi network membrane; ISS:UniProtKB.
DR   GO; GO:0017083; F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; ISO:RGD.
DR   GO; GO:0008417; F:fucosyltransferase activity; NAS:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0036065; P:fucosylation; ISS:UniProtKB.
DR   GO; GO:0006688; P:glycosphingolipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0106402; P:Lewis x epitope biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0036071; P:N-glycan fucosylation; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IDA:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0036445; P:neuronal stem cell division; ISS:UniProtKB.
DR   GO; GO:0009312; P:oligosaccharide biosynthetic process; ISO:RGD.
DR   GO; GO:0000271; P:polysaccharide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0006486; P:protein glycosylation; ISO:RGD.
DR   GO; GO:0006487; P:protein N-linked glycosylation; ISS:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB.
DR   GO; GO:1903037; P:regulation of leukocyte cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:1903236; P:regulation of leukocyte tethering or rolling; ISS:UniProtKB.
DR   Gene3D; 3.40.50.11660; Glycosyl transferase family 10, C-terminal domain; 1.
DR   InterPro; IPR031481; Glyco_tran_10_N.
DR   InterPro; IPR001503; Glyco_trans_10.
DR   InterPro; IPR038577; GT10-like_C_sf.
DR   PANTHER; PTHR11929:SF10; 4-GALACTOSYL-N-ACETYLGLUCOSAMINIDE 3-ALPHA-L-FUCOSYLTRANSFERASE 9; 1.
DR   PANTHER; PTHR11929; ALPHA- 1,3 -FUCOSYLTRANSFERASE; 1.
DR   Pfam; PF17039; Glyco_tran_10_N; 1.
DR   Pfam; PF00852; Glyco_transf_10; 1.
DR   SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Lipid metabolism; Membrane; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..359
FT                   /note="4-galactosyl-N-acetylglucosaminide 3-alpha-L-
FT                   fucosyltransferase 9"
FT                   /id="PRO_0000221121"
FT   TOPO_DOM        1..11
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        12..32
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        33..359
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   REGION          63..168
FT                   /note="Acceptor-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   REGION          169..326
FT                   /note="Donor-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   REGION          327..359
FT                   /note="Acceptor-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   ACT_SITE        137
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         75
FT                   /ligand="a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-
FT                   glucosaminyl derivative"
FT                   /ligand_id="ChEBI:CHEBI:133507"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         137
FT                   /ligand="a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-
FT                   glucosaminyl derivative"
FT                   /ligand_id="ChEBI:CHEBI:133507"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         137
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         168
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         192
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         194
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         195
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         202
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         226
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         241
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         246
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         252
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         255
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   BINDING         256
FT                   /ligand="GDP-beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:57273"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   CARBOHYD        62
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        153
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231, ECO:0000255"
FT   DISULFID        82..335
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   DISULFID        91..338
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
FT   DISULFID        190..238
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y231"
SQ   SEQUENCE   359 AA;  42037 MW;  369B4A7BD0C6CC80 CRC64;
     MTSTSKGILR PFLIVCIILG CFVACLLIYI KPTNSWVFSP MESASSVLKM KNFFSRKTDY
     FNETTILVWV WPFGQTFDLT SCQAMFNIQG CHLTTDRSLY NKSHAVLIHH RDISWDLTNL
     PQQARPPFQK WIWMNLESPT HTPQKSGIEH LFNLTLTYRR DSDIQVPYGF LTVSTSPFVF
     EVPSKEKLVC WVVSNWNPEH ARVKYYNELS KSIEIHTYGQ AFGEYVNDKN LIPTISTCKF
     YLSFENSIHK DYITEKLYNA FLAGSVPVVL GPSRENYENY IPADSFIHVE DFNSPSELAK
     YLKEVDKNNK LYLSYFNWRK DFTVNLPRFW ESHACLACDH VKRHQEYKSV GNLEKWFWN
//
